TrialBMC neurology2023

A feasibility and safety study of afamelanotide in acute stroke patients - an open label, proof of concept, phase iia clinical trial.

Vimal Stanislaus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.